Receive monthly emails about the latest oncology research and technology, new patient services, resources and more!

Please select an option below to help us tailor your newsletter to best suit your content interests!

No thanks

2021 West Oncology Conference

Posted by & filed under Uncategorized.

The 6th Annual West Oncology Conference will serve as a valuable forum for the presentation and discussion of new research findings. Participants will be provided with an update on practice-changing data on women’s cancers, genitourinary malignancies, disparities in cancer care, gastrointestinal cancers, hematological malignancies, and lung cancer in a practical and interactive format, fostering discussion… Read more »

Dr. Gregory Vidal Discusses Use of Patient Registries in Neratinib Study

Posted by & filed under Uncategorized.

Gregory Vidal, MD, PhD, West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in HER2-positive breast cancer.   Gregory Vidal, MD, PhD, of West Cancer Center and Research Institute, discusses the methodology of the Neat-HER study on neratinib in the extended adjuvant setting in… Read more »

OneR and West Cancer Physicians Give Ten Presentations at SABCS

Posted by & filed under Uncategorized.

OneR and West Cancer Physicians Give Ten Presentations at SABCS   OneOncology, the national network of independent oncology practices, announced today that physicians from OneR, the OneOncology Research Network and West Cancer and Research Institute will share results from ten research studies at the San Antonio Breast Cancer Symposium® (SABCS®), an international gathering of physicians and… Read more »

West Cancer Center & Research Institute, through affiliate OneR & Genentech, Launches New Clinical Trial Targeting Actionable Mutation Study in Cancer

Posted by & filed under Uncategorized.

Matching patient populations with a targetable genomic alteration to a specific investigational study is the aim of a new clinical trial through OneR and Genentech. This partnership will facilitate collaborations on various clinical trials, scientific research and real-world data studies that will advance personalized cancer care at community oncology centers like West. “With too many… Read more »

JAK Pseudokinase Domain Variants Highlight nRTK nsSNPs Identified with Next-Generation

Posted by & filed under Clinical Publications and Presentations, Medical Conferences.

Matthew Stein, MD (Hematology/Oncology) Presenting at: IASLC (Int’l Assoc. for the Study of Lung Cancer) Yokohama, Japan-October 16, 2017 Abstract 10429 JAK Pseudokinase Domain Variants Highlight nRTK nsSNPs Identified with Next-Generation Sequencing in NSCLC Patients Type:      Peer Review  Topic:     02. Biology/Pathology Authors: Matthew K. Stein, Lindsay K. Morris, Mike G. Martin; West Cancer Center, University… Read more »

X